Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.

@article{Wlodawer1998InhibitorsOH,
  title={Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.},
  author={A. Wlodawer and J. Vondrasek},
  journal={Annual review of biophysics and biomolecular structure},
  year={1998},
  volume={27},
  pages={
          249-84
        }
}
Retroviral protease (PR) from the human immunodeficiency virus type 1 (HIV-1) was identified over a decade ago as a potential target for structure-based drug design. This effort was very successful. Four drugs are already approved, and others are undergoing clinical trials. The techniques utilized in this remarkable example of structure-assisted drug design included crystallography, NMR, computational studies, and advanced chemical synthesis. The development of these drugs is discussed in… Expand
601 Citations
Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design.
  • M. Li, G. Laco, +4 authors A. Gustchina
  • Medicine, Biology
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2005
  • 43
  • PDF
Molecular Basis for Drug Resistance in HIV-1 Protease
  • 108
  • PDF
HIV protease inhibition: limited recent progress and advances in understanding current pitfalls.
  • 52
  • PDF
Computational study of the resistance shown by the subtype B/HIV-1 protease to currently known inhibitors.
  • 18
HIV-1 protease folding and the design of drugs which do not create resistance.
  • 36
  • PDF
Peptide Inhibition of HIV-1
  • 15
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 170 REFERENCES
Structural mechanisms of HIV drug resistance.
  • 160
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.
  • 221
  • PDF
Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors.
  • 92
Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.
  • 111
  • PDF
Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design.
  • 25
The three-dimensional x-ray crystal structure of HIV-1 protease complexed with a hydroxyethylene inhibitor.
  • 14
Rational design of peptide-based HIV proteinase inhibitors.
  • 802
  • PDF
...
1
2
3
4
5
...